A growing number of 23andMe users are distancing themselves from the once-popular genetic testing company, as mounting ...

Texas is suing 23andMe to prevent the genetic testing firm from selling personal data of state residents as the company's ...

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

If you like what we do here, forward this email to a friend. They can get this newsletter every week through a STAT+ subscription, which is 50% off through next Monday.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...

Multiple states and the District Columbia are pushing back on bankrupt 23andMe’s plans to sell customer genetic information ...

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

The DNA of 15 million people was sold after 23andMe filed for bankruptcy and was acquired by pharmaceutical giant Regeneron.

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.